Inactive
U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Senior Associate Scouting and Partnering - Scientific Search Evaluation

Biology & BiotechPosted on Aug 31
Full-timeShanghai, ChinaNo salary listed

About the Job

Responsibilities

  • Scout pharmaceutical and biotechnology companies and academia for external assets or programs aligned with UCB’s strategic therapeutic interests, using existing or newly established networks, external forums in China and East/South East Asia, and available search databases.
  • Bring ideas from the external environment to support or add to UCB’s internal neurology pipeline and provide input into strategy for research areas.
  • Act as due diligence expert lead or coordinator within a larger due diligence team and proactively provide recommendations to decision committees.
  • Critically assess preclinical and clinical data packages and provide an integrated viewpoint on opportunities to senior management.
  • Build and continuously expand a curated domestic network of immunology, neurology, or neuromuscular stakeholders, including academic principal investigators, biotechs, translational institutions, and local venture capital investors.
  • Conduct regular laboratory visits and industry outreach to source undisclosed early-stage Chinese assets.
  • Support negotiations and early governance of China-centric partnership structures, including co-development frameworks, joint research labs, and option-to-acquire arrangements.
  • Coordinate cross-border compliance for human genetic resources and cross-sample sharing for China-originated collaborations.
  • Compile regular China therapeutic landscape intelligence reports covering modalities, domestic competitive pipelines, Center for Drug Evaluation policy updates, and local investment trends.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs